Antidepressant adherence and medical resource use among managed care patients with anxiety disorders

Psychiatric Services

Volumn 57, Issue 5, 2006, Pages 673-680

  Stein, Murray B ^a   Cantrell, Christopher Ron ^b,c   Sokol, Michael C ^b,c   Eaddy, Michael T ^d   Shah, Manan B ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Applied Health Outcomes ^*

^d XCENDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; DRUG COST; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION;

EID: 33646462171     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2006.57.5.673     Document Type: Article

References (36)

1. Stein MB: Attending to anxiety disorders in primary care. Journal of Clinical Psychiatry 64(suppl 15):33-39, 2003
2. Kessler RC, Berglund P, Demler O, et al: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:593-602, 2005
3. Arikian S, Gorman J: A review of the diagnosis, pharmacologic treatment, and economic aspects of anxiety disorders. Primary Care Companion of the Journal of Clinical Psychiatry 3:110-117, 2001
4. Olfson M, Marcus SC, Wan GJ, et al: National trends in the outpatient treatment of anxiety disorders. Journal of Clinical Psychiatry 65:1166-1173, 2004
5. Bruce SE, Vasile RG, Goisman RM, et al: Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? American Journal of Psychiatry 160:1432-1438, 2003
6. Practice guideline for the treatment of patients with panic disorder: Work Group on Panic Disorder: American Psychiatric Association. American Journal of Psychiatry 155 (suppl 5):1-34, 1998
7. Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. American Psychiatric Association, 2004. Available at www.psych.org/psychpract/treatg/pg/ptsd-pg-partsa-b-c-new.pdf
8. Ballenger JC, Davidson JRT, Lecrubier Y, et al: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry 62(suppl 11):53-58, 2001
9. Simon NM, Emmanuel N, Ballenger J, et al: Bupropion sustained release for panic disorder. Psychopharmacology Bulletin 37: 66-72, 2003
10. Lin EH, Von Korff M, Katon W, et al: The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care 33:67-74, 1995
11. Eaddy M, Bramley T, Regan T: Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors. Managed Care Interface 16:22-27, 2003
12. Thompson D, Buesching D, Gregor KJ, et al: Patterns of antidepressant use and their relation to costs of care. American Journal of Managed Care 2:1239-1246, 1995
13. White TJ, Vanderplas A, Ory C, et al: Economic impact of patient adherence with antidepressant therapy within a managed care organization. Disease Management and Health Outcomes 11:817-822, 2003
14. Sheehan DV, Eaddy M, Sarnes M, et al: Evaluating the economic consequences of early antidepressant treatment discontinuation. Journal of Clinical Psychopharmacology 24:544-548, 2004
15. Katon W, Von Korff M, Lin E, et al: Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. General Hospital Psychiatry 12: 355-362, 1990
16. Schmitz N, Kruse J: The relationship between medical disorders and medical service utilization in a representative community sample. Social Psychiatry and Psychiatric Epidemiology 37:380-386, 2002
17. Sanderson K, Andrews G: Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatric Services 53:80-86, 2002
18. Rapaport MH, Clary C, Fayyad R, et al: Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry 162:1171-1178, 2005
19. Katon WJ, Von Korff M, Lin E: Panic disorder: relationship to high medical utilization. American Journal of Medicine 92:7S-11S, 1992
20. Katon WJ, Roy-Byrne PP, Russo J, et al: Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Archives of General Psychiatry 59:1098-1104, 2002
21. Steiner J, Prochazka A: The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of Clinical Epidemiology 50:105-116, 1997
22. Health Plan Employer Data and Information Set (HEDIS). National Committee for Quality Assurance, 2005
23. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40:373-383, 1987
24. Deyo R, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 45:613-619, 1992
25. Lewis E, Marcus SC, Olfson M, et al: Patients' early discontinuation of antidepressant prescriptions. Psychiatric Services 55:494, 2004
26. Stein MB, Sherbourne CD, Craske MG, et al: Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry 161:2230-2237, 2004
27. Wang PS, Lane M, Olfson M, et al: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62:629-640, 2005
28. Bull SA, Hunkeler EM, Lee JY, et al: Discontinuing or switching selective serotonin-reuptake inhibitors. Annals of Pharmacotherapy 26:578-584, 2002
29. Cantrell CR, Eaddy MT, Shah MB, et al: Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Medical Care 44:300-303, 2006
30. Ballenger JC: Anxiety and depression: optimizing treatments. Primary Care Companion to the Journal of Clinical Psychiatry 2:71-79, 2000
31. Altamura AC, Montresor C, Salvadori D, et al: Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study. International Journal of Neuropsychopharmacology 7: 1-7, 2004
32. Kessler RC, Nelson CB, McGonagle KA, et al: Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. British Journal of Psychiatry 168(suppl 30):17-30, 1996
33. Roy-Byrne PP, Katon W, Cowley DS, et al: A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Archives of General Psychiatry 58:869-876, 2001
34. Roy-Byrne PP, Craske MG, Stein MB, et al: A randomized effectiveness trial of cognitive behavior therapy and medication for primary care panic disorder. Archives of General Psychiatry 62:290-298, 2005
35. Jolis JG, Ancukiewicz M, DeLong E, et al: Discordance of databases designed for claims payment versus clinical information systems. Annals of Internal Medicine 119: 844-850, 1993
36. Greenberg PE, Sisitsky T, Kessler RC, et al: The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry 60:427-435, 1999